NRXP NRx Pharmaceuticals, Inc.
$2.15
NRx Pharmaceuticals, Inc. (NRXP) Earnings News
Earnings press releases, previews and reviews for NRx Pharmaceuticals, Inc. (NRXP), newest first. Our most recent is review: NRx Pharmaceuticals Beats on EPS as First FDA Approval Arrives, but Operating Losses and Slipping Timelines Undercut the Headline.
Tuesday
November 17, 2026
10:41 AM ET
NRx Pharmaceuticals Beats on EPS as First FDA Approval Arrives, but Operating Losses and Slipping Timelines Undercut the Headline
Earnings Whispers · Review
Tuesday
November 17, 2026
7:18 AM ET
NRx Pharmaceuticals (Nasdaq: NRXP) Reports Third Quarter 2026 Financial Results and Provides Corporate Update
Friday
November 13, 2026
8:17 AM ET
NRx Pharmaceuticals Faces a Revenue Proof Test as Losses Are Expected to Deepen
Earnings Whispers · Preview
Thursday
November 12, 2026
4:01 PM ET
NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) to Report Third Quarter 2026 Financial Results and Provide Corporate Update
Monday
August 17, 2026
7:00 AM ET
NRx Pharmaceuticals (Nasdaq:NRXP) Reports Second Quarter 2026 Financial Results and Provides Corporate Update; Conference Call to be Held on Monday, August 17th at 4:30pm ET